Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the study page still displays a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe study record view is replaced by a 403 Forbidden message and a Home link, leaving the trial details unavailable.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page now displays a 403 Forbidden error with minimal navigation (e.g., Home) and a Revision notice, replacing the previously visible study details and documents.SummaryDifference19%

- Check47 days agoChange DetectedThe page shows an update from revision v3.6.5 to v3.6.6, reflecting a site maintenance/version bump. This does not change the study information or how the NCT03907878 trial is presented.SummaryDifference0.1%

- Check68 days agoChange DetectedThe footer revision tag was updated to v3.6.5, indicating a minor release of the page's documentation. This does not modify the study details or participant information.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating the page has been updated to a newer revision.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.